Menu Search
Equities

SyntheticMR AB (publ)

SYNT:AKT

SyntheticMR AB (publ)

Actions
  • Price (SEK)12.00
  • Today's Change0.10 / 0.84%
  • Shares traded20.65k
  • 1 Year change-45.45%
  • Beta0.7819
Data delayed at least 15 minutes, as of Sep 13 2024 17:00 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Forecasts data is unavailable for this security.

Consensus recommendation

  • 14-Sep-23
  • 20-Jun-24
  • 18-Jul-24
  • 15-Aug-24
  • 12-Sep-24
Select bar for recommendation details.
Recommendations12-Sep-24
Buy0
Outperform1
Hold1
Sell0
Strong Sell0

Share price forecast in SEK

The 2 analysts offering 12 month price targets for SyntheticMR AB (publ) have a median target of 19.00, with a high estimate of 20.00 and a low estimate of 18.00. The median estimate represents a 56.38% increase from the last price of 12.15.
High64.6%20.00
Med56.4%19.00
Low48.1%18.00

Dividends

Dividend information is not available for SyntheticMR AB (publ).
Div growth (TTM)--
More ▼

Earnings history & estimates in SEK

On Aug 27, 2024, SyntheticMR AB (publ) reported 2nd quarter 2024 losses of -0.18 per share.
The next earnings announcement is expected on Nov 13, 2024.
Average growth rate+11.85%
SyntheticMR AB (publ) reported annual 2023 earnings of 0.21 per share on Feb 20, 2024.
Average growth rate+411.22%
More ▼

Revenue history & estimates in SEK

SyntheticMR AB (publ) had 2nd quarter 2024 revenues of 11.92m. This missed the 12.00m estimate of the one analyst following the company. This was 26.16% below the prior year's 2nd quarter results.
Average growth rate-10.02%
SyntheticMR AB (publ) had revenues for the full year 2023 of 69.93m. This was 2.43% above the prior year's results.
Average growth rate+11.39%
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.